Article Details
Retrieved on: 2025-03-21 10:22:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses how U.S. trade policies under Trump aimed to address trade imbalances, tariffs, and protectionism impacting American industries, including biopharma, by countering unfair practices from countries like China and the EU, affecting market access and economic competition.
Article found on: itif.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here